Daily Markup

Daily Markup #929: Prenetics to conduct R&D at the International Space Station to bring advances in aging and longevity to people back on Earth

February 20, 2024 · 2 min read
Photo credit: Prenetics

Out of this world

  • 500-backed biotech company Prenetics is taking healthcare innovations into space — and back! They have committed to a strategic investment in Metavisionaries, a space and frontier technology company, and a pioneering five-year research agreement.
  • Under the agreement, a Space Innovation Lab will also be established within the UAE Space Agency. The inaugural Prenetics research cube is scheduled to on-board the SpaceX to the International Space Station in Q4 2024.
  • The first project Prenetics will undertake is with the Botnar Institute for Musculoskeletal Sciences at the University of Oxford. The research will look into cellular solutions that promote rejuvenation and vitality to combat the phenomenon of accelerated aging in space due to its zero-gravity environment. The potential of this research could lead to new advances in healthcare, enhancing cellular health and longevity for all ages on Earth.
  • Dr. James L. Green, former Chief Scientist of NASA and Dr. Tara Ruttley, former Associate Chief Scientist of NASA joined Prenetics Scientific Advisory Board
  • Danny Yeung, CEO of Prenetics shared, “Our collaboration with Metavisionaries underscores our dedication to innovation and our conviction in the transformative potential of space exploration to deliver ground-breaking health advancements on Earth.”
  • Read the full story here.
Daily
Tags:
0
Share
• • • KEEP READING

Daily Markup

  • Daily Markup is brought to you by 500 Southeast Asia & 500 Global

  • This website is updated as of August 3, 2022. All content herein is intended solely for general informational or educational purposes only. 500 Startups Management Company, L.L.C. and its affiliates (collectively “500 Startups”) makes no representation as to the accuracy or information in this post and while reasonable steps have been taken to ensure that the information herein is accurate and up-to-date, no liability can be accepted for any error or omissions. All third party links in this post have not been independently verified by 500 Startups and the inclusion of such links should not be interpreted as an endorsement or confirmation of the content within. Information about portfolio companies’ markets, competitors, performance, and fundraising has been provided by those companies’ founders and has not been independently verified. Under no circumstances should any content in this post be construed as investment, legal, tax or accounting advice by 500 Startups, or an offer to provide any investment advisory service with regard to securities by 500 Startups. No content or information in this post should be construed as an offer to sell or solicitation of interest to purchase any securities advised by 500 Startups. Prospective investors considering an investment into any 500 Startups fund should not consider or construe this content as fund marketing material. The views expressed herein are as at the date of this post and are subject to change without notice. One or more 500 Startups fund may have a financial interest in one or more of the companies discussed

    All users of this website should note these important Terms of Use governing the use of this website.

  • Copyright © 2022 500 Global | All Rights Reserved

  • Privacy Policy
    Terms of Use
    Code of Conduct